BillionToOne, Inc.
BLLN
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.65B
Close$
$116.62
15.3% upside
Current Fair Value
15.3% upsideUndervalued by 15.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.65 Billion |
|---|---|
| Enterprise Value | $4.26 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.06 |
| Beta | 0.9 |
| Outstanding Shares | 45,932,719 |
Return
| Return on Equity | 4.99% |
|---|---|
| Return on Assets | 3.60% |
| Return on Invested Capital | 5.22% |
Valuation & Multiples
| P/E Ratio | 184.26 |
|---|---|
| PEG | -33.46 |
| Price to Sales | 14.45 |
| Price to Book Ratio | 9.19 |
| Enterprise Value to Revenue | 12.02 |
| Enterprise Value to EBIT | 126.92 |
| Enterprise Value to Net Income | 169 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$97.14 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$109.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.4715▲ 247.15% |
|---|---|
| Total Calls | 19,300▲ Infinity% |
| Total Puts | 47,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.76%▲ 3.18% |
|---|---|
| Total Invested | $875.09M▲ 10.81% |
| Investors Holding | 93▲ 4.00% |
ESG Score
No data
About BillionToOne, Inc.
620 employees
CEO: Oguzhan Atay BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to...